Sign up for the daily Inside Washington email for exclusive US coverage and analysis sent to your inbox
Get our free Inside Washington email
Get our free Inside Washington email
A pharmaceutical executive collapsed in the Oval Office Thursday as members of the Trump administration were announcing a new deal for weight-loss medications.
The executive, believed to be Novo Nordisk executive Gordon Findlay, was standing behind the president during the event when, suddenly, his knees buckled from underneath him.
Reporters who witnessed the incident first-hand said Dr. Mehmet Oz, the Administrator for Centers for Medicare & Medicaid Services, helped the executive to the ground, preventing him from hitting his head. As reporters were ushered out of the Oval Office, cabinet members attended to the man, elevating his legs.
White House Press Secretary Karoline Leavitt said in a statement, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
An executive from a pharmaceutical company collapsed during an Oval Office event Thursday (Reuters)
This is a breaking news story, more follows…
